Lars Fruergaard Jorgensen | President and Chief Executive Officer |
Karsten Munk Knudsen | Executive Vice President and Chief Financial Officer |
Mads Krogsgaard Thomsen | Executive Vice President, Chief Scientific Officer and Head of R&D |
Camilla Sylvest | Executive Vice President, Commercial Strategy & Corporate Affairs |
Wimal Kapadia | Bernstein |
Peter Sehested | Handelsbanken |
Martin Parkhoi | Danske Bank |
Simon Baker | Redburn |
Steve Scala | Cowen |
Peter Verdult | Citi |
Hello, and welcome to the Q3 2020 Novo Nordisk A/S Earnings Conference Call. [Operator Instructions] Today, I'm pleased to present Lars Fruergaard Jorgensen. Please go ahead with your meeting.
Thank you. Welcome to this Novo Nordisk conference call regarding our performance for the first nine months of 2020 and our financial outlook for 2020.